{"id":28454,"date":"2021-02-11T12:57:00","date_gmt":"2021-02-11T12:57:00","guid":{"rendered":"http:\/\/patrocinados.estadao.com.br\/medialab\/agenciacomunicacao\/prnewswire\/prnewsbrasil\/pr-newswire-brasil-zymo-research-lanca-servico-de-sequenciamento-da-covid-19-para-deteccao-e-supervisao-de-variantes-emergentes-do-sars-cov-2\/"},"modified":"2021-02-11T12:57:00","modified_gmt":"2021-02-11T12:57:00","slug":"pr-newswire-brasil-zymo-research-lanca-servico-de-sequenciamento-da-covid-19-para-deteccao-e-supervisao-de-variantes-emergentes-do-sars-cov-2","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewsbrasil\/pr-newswire-brasil-zymo-research-lanca-servico-de-sequenciamento-da-covid-19-para-deteccao-e-supervisao-de-variantes-emergentes-do-sars-cov-2\/","title":{"rendered":"PR NEWSWIRE &#8211; BRASIL :: Zymo Research lan\u00e7a servi\u00e7o de sequenciamento da covid-19 para detec\u00e7\u00e3o e supervis\u00e3o de variantes emergentes do SARS-CoV-2"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h1 class=\"xn-hedline\">Zymo Research lan\u00e7a servi\u00e7o de sequenciamento da covid-19 para detec\u00e7\u00e3o e supervis\u00e3o de variantes emergentes do SARS-CoV-2<\/h1>\n<h2 class=\"xn-hedline\">Relat\u00f3rio r\u00e1pido com alto rendimento permite a detec\u00e7\u00e3o de poss\u00edveis cepas variantes que podem n\u00e3o ser combatidas pela vacina<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<p class=\"xn-dateline\">IRVINE, Calif., 11 de fevereiro de 2021<\/p>\n<\/div>\n<div class=\"xn-content\">\n<span class=\"xn-location\">IRVINE, Calif.<\/span>, 11 de fevereiro de 2021 \/PRNewswire\/ &#8212;\u00a0A Zymo Research anunciou hoje seu <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=1173586497&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D2083770488%26u%3Dhttps%253A%252F%252Fzymoresearch.com%252Fpages%252Fcovid19-variant-sequencing-service%253Futm_source%253DPRNewswire%2526utm_medium%253DPress_Release%2526utm_campaign%253Dvariant_service_press_release_2.10.21%2526utm_content%253Dpress_release_hyperlink%26a%3DCOVID-19%2BVariant%2BSequencing%2BService.&amp;a=servi%C3%A7o+de+sequenciamento+de+variantes+da+covid-19.\" rel=\"noopener\">servi\u00e7o de sequenciamento de variantes da covid-19.<\/a>\u00a0Este novo servi\u00e7o global amplia as solu\u00e7\u00f5es de ponta a ponta da Zymo Research em rela\u00e7\u00e3o ao SARS-CoV-2 que incluem coleta de amostras, extra\u00e7\u00e3o de RNA e detec\u00e7\u00e3o do SARS-CoV-2. Detectar muta\u00e7\u00f5es de forma r\u00e1pida ajuda a evitar a dissemina\u00e7\u00e3o de novos tipos de cepas virais e pode fornecer um alerta antecipado sobre poss\u00edvel n\u00e3o efetividade da vacina.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2788\">\n<a href=\"https:\/\/mma.prnewswire.com\/media\/1437314\/Zymo_COVID_19_Variant_Identification_Service_PR.html\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1437314\/Zymo_COVID_19_Variant_Identification_Service_PR.jpg\" alt=\"Zymo Research apresenta seu servi\u00e7o de sequenciamento de variantes da covid-19 que auxilia no rastreamento do surgimento e da preval\u00eancia de novas variantes de SARS-CoV-2. (PRNewsfoto\/Zymo Research Corp.)\" \/><\/a><\/p>\n<\/div>\n<p>A Zymo Research, prestadora de servi\u00e7os de sequenciamento certificada pela Illumina, utiliza o fluxo de trabalho Illumina COVIDSeq<sup>?<\/sup> NGS. O servi\u00e7o de ponta a ponta inclui os dispositivos de coleta necess\u00e1rios e a tecnologia de extra\u00e7\u00e3o automatizada, com sequenciamento de RNA conclu\u00eddo em plataformas Illumina. O <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=1172861935&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D4229145700%26u%3Dhttps%253A%252F%252Fwww.zymoresearch.com%252Fpages%252Fdna-rna-shield-viral%253Futm_source%253DPRNewswire%2526utm_medium%253DPress_Release%2526utm_campaign%253Dvariant_service_press_release_2.10.21%2526utm_content%253Dpress_release_hyperlink%26a%3DDNA%252FRNA%2BShield&amp;a=DNA%2FRNA+Shield\" rel=\"noopener\">DNA\/RNA Shield<\/a><sup>? <\/sup>da Zymo Research \u00e9 utilizado para coleta, transporte e preserva\u00e7\u00e3o das amostras. O conservante inativa o SARS-CoV-2 ao mesmo tempo em que estabiliza seu RNA, permitindo o transporte de temperatura ambiente seguro para sequenciamento e prepara\u00e7\u00e3o de literatura m\u00e9dica robusta.<\/p>\n<p>&#8220;A Zymo Research continua a exercer um papel significativo no combate \u00e0 pandemia atual da covid-19&#8221;, disse o Dr. <span class=\"xn-person\">Keith Booher<\/span>, l\u00edder de servi\u00e7os da Zymo Research. &#8220;Na medida em que o SARS-CoV-2 apresenta muta\u00e7\u00f5es, assumimos o compromisso de desenvolver produtos e servi\u00e7os em nosso portf\u00f3lio de testes da covid-19 para ajudar organiza\u00e7\u00f5es de sa\u00fade e laborat\u00f3rios governamentais em \u00e2mbito local e federal na identifica\u00e7\u00e3o de novas variantes de interesse em rela\u00e7\u00e3o ao coronav\u00edrus, incluindo as rec\u00e9m-surgidas cepas do Reino Unido (b.1.1,7), da \u00c1frica do Sul (B.1.351) e do Brasil (P.1).&#8221;<\/p>\n<p>O fluxo de trabalho de servi\u00e7os de sequenciamento de variantes da covid-19 consiste em coleta de amostras, processamento, sequenciamento e relat\u00f3rios. Amostras positivas quanto \u00e0 covid s\u00e3o coletadas de centros de testes e transportadas para a Zymo Research e suas afiliadas para fins de processamento. A extra\u00e7\u00e3o automatizada de RNA das amostras coletadas \u00e9 realizada utilizando a plataforma rob\u00f3tica KingFisher<sup>?<\/sup> Flex. O sequenciamento \u00e9 realizado usando a tecnologia de sequenciamento por s\u00edntese da Illumina e, em seguida, analisado usando o pipeline de an\u00e1lise DRAGEN<sup>?<\/sup> COVIDSeq<sup>?<\/sup> acelerado por hardware. O relat\u00f3rio final inclui identifica\u00e7\u00e3o de cepas da covid-19, cobertura de sequenciamento de genoma, muta\u00e7\u00f5es confirmadas, genoma de consenso e arquivos de sequ\u00eancia bruta.<\/p>\n<p>Para mais informa\u00e7\u00f5es e pre\u00e7os, acesse o <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=2682514787&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D4280931956%26u%3Dhttps%253A%252F%252Fzymoresearch.com%252Fpages%252Fcovid19-variant-sequencing-service%253Futm_source%253DPRNewswire%2526utm_medium%253DPress_Release%2526utm_campaign%253Dvariant_service_press_release_2.10.21%2526utm_content%253Dpress_release_hyperlink%26a%3Dwebsite&amp;a=site\" rel=\"noopener\">site<\/a>\u00a0da Zymo Research ou entre em contato pelo e-mail <a target=\"_blank\" href=\"mailto:covid19requests@zymoresearch.com?subject=COVID-19%20Variant%20Sequencing%20Service\" rel=\"noopener\">covid19requests@zymoresearch.com<\/a>.<\/p>\n<p><b>Informa\u00e7\u00f5es sobre a Zymo Research Corp.<br \/><\/b>A Zymo Research \u00e9 uma empresa de capital fechado que atende \u00e0 comunidade cient\u00edfica e de diagn\u00f3sticos com ferramentas de biologia molecular de \u00faltima gera\u00e7\u00e3o desde 1994. &#8220;A beleza da ci\u00eancia \u00e9 simplificar as coisas&#8221; \u00e9 o lema da empresa, que se reflete em todos os seus produtos, desde epigen\u00e9tica at\u00e9 tecnologias de purifica\u00e7\u00e3o de DNA\/RNA. Historicamente reconhecida como l\u00edder em epigen\u00e9tica, a Zymo Research est\u00e1 rompendo fronteiras com novas solu\u00e7\u00f5es para coleta de amostras, medi\u00e7\u00f5es de microbiomas, dispositivos de diagn\u00f3stico e tecnologias de NGS que s\u00e3o de alta qualidade e simples de usar. Siga a Zymo Research no <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=3357719846&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D3160788738%26u%3Dhttps%253A%252F%252Fwww.facebook.com%252Fzymoresearch%26a%3DFacebook&amp;a=Facebook\" rel=\"noopener\">Facebook<\/a>, <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=4243179657&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D441941788%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fzymo-research-corp%252F%26a%3DLinkedIn&amp;a=LinkedIn\" rel=\"noopener\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=3025958212&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D3658543216%26u%3Dhttps%253A%252F%252Ftwitter.com%252FZymoResearch%26a%3DTwitter&amp;a=Twitter\" rel=\"noopener\">Twitter<\/a>\u00a0e <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=2321334515&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D3649452742%26u%3Dhttps%253A%252F%252Fwww.instagram.com%252Fzymoresearch%252F%26a%3DInstagram&amp;a=Instagram\" rel=\"noopener\">Instagram<\/a>.<\/p>\n<p>Para obter mais informa\u00e7\u00f5es sobre os produtos da Zymo Research para covid-19, acesse os links a seguir:<\/p>\n<p><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=212398102&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D3822132179%26u%3Dhttps%253A%252F%252Fwww.prnewswire.com%252Fnews-releases%252Fzymo-research-releases-free-software-to-streamline-covid-19-test-reporting-301100732.html%253Ftc%253Deml_cleartime%26a%3DZymo%2BResearch%2BReleases%2BFree%2BSoftware%2Bto%2BStreamline%2BCOVID-19%2BTest%2BReporting&amp;a=Zymo+Research+lan%C3%A7a+software+gratuito+para+agilizar+o+relat%C3%B3rio+de+testes+de+covid-19\" rel=\"noopener\">Zymo Research lan\u00e7a software gratuito para agilizar o relat\u00f3rio de testes de covid-19<\/a>\u00a0<br \/><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=489375896&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D1317523125%26u%3Dhttps%253A%252F%252Fwww.prnewswire.com%252Fin%252Fnews-releases%252Fzymo-research-obtains-ce-ivd-mark-for-its-quick-sars-cov-2-multiplex-kit-842686546.html%26a%3DZymo%2BResearch%2BObtains%2BCE%2BIVD%2BMark%2Bfor%2Bits%2BQuick%2BSARS-CoV-2%2BMultiplex%2BKit&amp;a=Zymo+Research+obt%C3%A9m+a+marca+CE+IVD+para+seu+Kit+Quick+SARS-CoV-2+Multiplex\" rel=\"noopener\">Zymo Research obt\u00e9m a marca CE IVD para seu Kit Quick SARS-CoV-2 Multiplex<\/a>\u00a0<br \/><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=3593231073&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D2759901200%26u%3Dhttps%253A%252F%252Fwww.prnewswire.com%252Fnews-releases%252Fzymo-research-obtains-emergency-use-authorization-from-fda-for-their-quick-sars-cov-2-rrt-pcr-kit-301057233.html%26a%3DZymo%2BResearch%2BObtains%2BEmergency%2BUse%2BAuthorization%2Bfrom%2BFDA%2Bfor%2BTheir%2BQuick%2BSARS-CoV-2%2BrRT-PCR%2BKit&amp;a=Zymo+Research+obt%C3%A9m+autoriza%C3%A7%C3%A3o+da+FDA+para+uso+emergencial+do+Kit+Quick+SARS-CoV-2+rRT-PCR\" rel=\"noopener\">Zymo Research obt\u00e9m autoriza\u00e7\u00e3o da FDA para uso emergencial do Kit Quick SARS-CoV-2 rRT-PCR<\/a>\u00a0<br \/><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=1925740438&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D181100400%26u%3Dhttps%253A%252F%252Fwww.prnewswire.com%252Fin%252Fnews-releases%252Fzymo-research-receives-ce-ivd-mark-for-its-quick-dna-rna-tm-viral-magbead-kit-803100122.html%26a%3DZymo%2BResearch%2BReceives%2BCE%2BIVD%2BMark%2Bfor%2Bits%2BQuick-DNA%252FRNA%25E2%2584%25A2%2BViral%2BMagBead%2BKit&amp;a=Zymo+Research+recebe+a+marca+CE+IVD+para+seu+Kit+Quick-DNA%2FRNA%E2%84%A2+Viral+MagBead\" rel=\"noopener\">Zymo Research recebe a marca CE IVD para seu Kit Quick-DNA\/RNA<sup>?<\/sup> Viral MagBead<\/a>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder9308\">\n<a href=\"https:\/\/mma.prnewswire.com\/media\/364743\/Zymo_Research_Corp_Logo.html\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/364743\/Zymo_Research_Corp_Logo.jpg\" alt=\"Zymo Research Corp. Logo\" \/><\/a><\/p>\n<\/div>\n<p>Foto\u00a0&#8211; <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=255244514&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1437314%2FZymo_COVID_19_Variant_Identification_Service_PR.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1437314%2FZymo_COVID_19_Variant_Identification_Service_PR.jpg\" rel=\"noopener\">https:\/\/mma.prnewswire.com\/media\/1437314\/Zymo_COVID_19_Variant_Identification_Service_PR.jpg<\/a> <br \/>Logotipo &#8211; <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=3065290-1&amp;h=1679162733&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3065290-1%26h%3D2243392634%26u%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F364743%252FZymo_Research_Corp_Logo.jpg%26a%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F364743%252FZymo_Research_Corp_Logo.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F364743%2FZymo_Research_Corp_Logo.jpg\" rel=\"noopener\">https:\/\/mma.prnewswire.com\/media\/364743\/Zymo_Research_Corp_Logo.jpg<\/a>\u00a0\u00a0<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p>FONTE  Zymo Research Corp.<\/p>\n<\/div>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PT77337&amp;Transmission_Id=202102111046PR_NEWS_LATAM____PT77337&amp;DateId=20210211\" \/><\/p>\n<p>PR NEWSWIRE<\/p>\n","protected":false},"excerpt":{"rendered":"Zymo Research lan\u00e7a servi\u00e7o de sequenciamento da covid-19 para detec\u00e7\u00e3o e supervis\u00e3o de variantes emergentes do SARS-CoV-2 Relat\u00f3rio r\u00e1pido com alto rendimento permite a detec\u00e7\u00e3o de","protected":false},"author":1,"featured_media":28455,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[28],"tags":[],"class_list":["post-28454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-prnewsbrasil"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/28454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=28454"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/28454\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media\/28455"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=28454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=28454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=28454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}